Small cell lung cancer: will recent progress lead to improved outcomes?

@article{Pietanza2015SmallCL,
  title={Small cell lung cancer: will recent progress lead to improved outcomes?},
  author={Maria Catherine Pietanza and Lauren A. Byers and John D. Minna and Charles M Rudin},
  journal={Clinical cancer research : an official journal of the American Association for Cancer Research},
  year={2015},
  volume={21 10},
  pages={2244-55}
}
Small cell lung cancer (SCLC) is an aggressive neuroendocrine malignancy with a unique natural history characterized by a short doubling time, high growth fraction, and early development of widespread metastases. Although a chemotherapy- and radiation-sensitive disease, SCLC typically recurs rapidly after primary treatment, with only 6% of patients… CONTINUE READING